Sars News
Most Popular Sars Story
Beleaguered Viragen liquidates assets
Everyone knows that the biotech drug development process is a gamble. Small developers spend years and tens if not hundreds of millions of dollars trying to bring drugs to market. The lucky ones will Read more...
Latest Headlines
- October 24, 2007
- August 24, 2007
Paid Research Reports
- Trends in mHealth and Telemedicine
- The Global Aesthetic Dermatology Market Outlook
- Future Directions in Regenerative Medicine
- Pipeline Insight: Insulin Antidiabetics – Novel analogs show promise as alternative delivery methods prove less attractive
- Pipeline Insight: Non-insulin Antidiabetics - Rise of the weight-reducers: Once-weekly GLP-1 agonists and novel SGLT-2 inhibitor
- Forecast Insight: Antidiabetics - Diabetes market growth driven by epidemiological trends and rich pipeline
